1887
  1. Home
  2. Eurosurveillance
  3. Volume 24, Issue 12, 21/Mar/2019
  4. Article
Editorial Open Access
Like 0
Download
Preview this article:
Preview Magnify

There is no abstract available.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2019.24.12.1900174
2019-03-21
2024-11-21
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2019.24.12.1900174
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/24/12/eurosurv-24-12-1.html?itemId=/content/10.2807/1560-7917.ES.2019.24.12.1900174&mimeType=html&fmt=ahah

References

  1. World Health Organization (WHO). Global tuberculosis report 2018. Geneva: WHO; 2018. Available from: https://www.who.int/tb/publications/global_report/en/
  2. World Health Organization Regional Office for Europe (WHO/Europe)/European Centre for Disease Prevention and Control (ECDC). Tuberculosis surveillance and monitoring in Europe 2019 – 2017 data. Copenhagen: WHO/Europe; 2019. Available from: www.ecdc.europa.eu/en/publications-data/tuberculosis-surveillance-and-monitoring-europe-2019
  3. Apolinário D, Ribeiro AI, Krainski E, Sousa P, Abranches M, Duarte R. Tuberculosis inequalities and socio-economic deprivation in Portugal. Int J Tuberc Lung Dis. 2017;21(7):784-9.  https://doi.org/10.5588/ijtld.16.0907  PMID: 28633703 
  4. Guthmann J, Aït Belghiti F, Lévy-Bruhl D. Épidémiologie de la tuberculose en France en 2015. Impact de la suspension de l’obligation vaccinale BCG sur la tuberculose de l’enfant, 2007-2015. [Epidemiology of tuberculosis in France in 2015. Impact of the suspension of the BCG vaccination obligation on childhood tuberculosis, 2007-2015]. Saint-Maurice: Santé publique France; 2017. French. Available from: http://invs.santepubliquefrance.fr/beh/2017/7/2017_7_1.html
  5. Robert Koch Institut (RKI). RKI-Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2017. [RKI-report on the epidemiology of tuberculosis in Germany for 2017]. Berlin: RKI; 2018. German. Available from: https://www.rki.de/DE/Content/InfAZ/T/Tuberkulose/Archiv_Berichte_TB_in_Dtl_tab.html
  6. World Health Organization (WHO). Implementing the end TB strategy: the essentials. Geneva: WHO; 2015. Available from: http://www.who.int/tb/publications/2015/end_tb_essential.pdf?ua=1
  7. Merk H, Ködmön C, van der Werf MJ. Will we reach the Sustainable Development Goals target for tuberculosis in the European Union/European Economic Area by 2030? Euro Surveill. 2019;24(12):1900153.  https://doi.org/10.2807/1560-7917.ES.2019.24.12.1900153 
  8. Karo B, Kohlenberg A, Hollo V, Duarte R, Fiebig L, Jackson S, et al. Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014. Euro Surveill. 2019;24(12):1800392.  https://doi.org/10.2807/1560-7917.ES.2019.24.12.1800392 
  9. Karo B, Hauer B, Hollo V, van der Werf MJ, Fiebig L, Haas W. Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002-2011. Euro Surveill. 2015;20(49):30087.  https://doi.org/10.2807/1560-7917.ES.2015.20.49.30087  PMID: 26676247 
  10. van der Werf MJ, Ködmön C, Hollo V, Sandgren A, Zucs P. Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012. Euro Surveill. 2014;19(10):20733.  https://doi.org/10.2807/1560-7917.ES2014.19.10.20733  PMID: 24650865 
  11. World Health Organization (WHO). TB: a global emergency. WHO report on the TB epidemic. Geneva: WHO; 1994. Available from: http://apps.who.int/iris/handle/10665/58749
  12. World Health Organization (WHO). New Global Commitment to fight tuberculosis. Geneva: WHO; 2017. Available from: https://www.who.int/news-room/detail/17-11-2017-new-global-commitment-to-end-tuberculosis
  13. World Health Organization (WHO). About the UN high-level meeting. Geneva: WHO; 2018. Available from: https://www.who.int/news-room/events/un-general-assembly-high-level-meeting-on-ending-tb/about-the-un-high-level-meeting
  14. Lönnroth K, Migliori GB, Abubakar I, D’Ambrosio L, de Vries G, Diel R, et al. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J. 2015;45(4):928-52.  https://doi.org/10.1183/09031936.00214014  PMID: 25792630 
  15. Hargreaves S, Lönnroth K, Nellums LB, Olaru ID, Nathavitharana RR, Norredam M, et al. Multidrug-resistant tuberculosis and migration to Europe. Clin Microbiol Infect. 2017;23(3):141-6.  https://doi.org/10.1016/j.cmi.2016.09.009  PMID: 27665703 
  16. Annesi-Maesano I. Ringing the alarm bells about migrants’ health. Int J Tuberc Lung Dis. 2018;22(2):123-4.  https://doi.org/10.5588/ijtld.17.0872  PMID: 29506607 
  17. Houben RM, Dodd PJ. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med. 2016;13(10):e1002152.  https://doi.org/10.1371/journal.pmed.1002152  PMID: 27780211 
  18. Rosales-Klintz S, Bruchfeld J, Haas W, Heldal E, Houben RMGJ, van Kessel F, et al. Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area. Eur Respir J. 2019;53(1):1802077.  https://doi.org/10.1183/13993003.02077-2018  PMID: 30655449 
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error